SCHEMBL989459

SCHEMBL989459

O=C(O)N1CC2=C(CCOc3ccc(Br)cc32)S1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 3/20 0.34
PIK3CB P42338 3/20 0.34
PIK3CG P48736 3/20 0.34
PIK3CD O00329 1/20 0.34
CYP19A1 P11511 1/20 0.34
MAPT P10636 2/20 0.33
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33
BLM P54132 1/20 0.33
APP P05067 3/20 0.33
RAB9A P51151 3/20 0.32
NPC1 O15118 2/20 0.32
MAOB P27338 2/20 0.32
GPR183 P32249 1/20 0.31
STING1 Q86WV6 2/20 0.31
MAOA P21397 1/20 0.31
NOTUM Q6P988 1/20 0.30
SRD5A1 P18405 1/20 0.30
SRD5A2 P31213 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL988493 0.90 PRMT5 (0.35) MAPTLMNAHTTBLMMAOB
SCHEMBL989471 0.89 NOTUM (0.34) PIK3CAPIK3CBPIK3CGPIK3CDCYP19A1
SCHEMBL15200696 0.86 RAB9A (0.33) PIK3CAPIK3CBPIK3CGPIK3CDMAPT
SCHEMBL989248 0.86 HDAC3 (0.34) PIK3CAPIK3CBPIK3CGPIK3CDMAPT
SCHEMBL1516965 0.85 KDM4E (0.41) PIK3CACYP19A1NOTUM
SCHEMBL988657 0.84 NPC1 (0.35) PIK3CAPIK3CBPIK3CGPIK3CDMAPT
SCHEMBL988075 0.82 PIK3CA (0.39) PIK3CAPIK3CBPIK3CDMAPTRAB9A
SCHEMBL989119 0.82 NOTUM (0.40) PIK3CAPIK3CBMAPTLMNAHTT
SCHEMBL15200769 0.81 AKR1B1 (0.32) MAOB
SCHEMBL1516828 0.80 MMP2 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2814830-A1 TRICYCLIC COMPOUNDS AND METHODS OF USE THEREFOR F.HOFFMANN-LA ROCHE AG (CH) 2014-12-24 EP disclosed
WO-2013120980-A1 TRICYCLIC COMPOUNDS AND METHODS OF USE THEREFOR F. HOFFMANN-LA ROCHE AG (CH) 2013-08-22 WO disclosed
EP-2483277-A1 BENZOXEPIN PI3K INHIBITOR COMPOUNDS AND METHODS OF USE F. Hoffmann-La Roche AG (CH) 2012-08-08 EP disclosed
WO-2011036284-A1 BENZOXEPIN PI3K INHIBITOR COMPOUNDS AND METHODS OF USE F. HOFFMANN-LA ROCHE AG (CH) 2011-03-31 WO disclosed
EP-2276767-A1 BENZOPYRAN AND BENZOXEPIN PI3K INHIBITOR COMPOUNDS AND METHODS OF USE Genentech, Inc. (US) 2011-01-26 EP disclosed
WO-2009123971-A1 BENZOPYRAN AND BENZOXEPIN PI3K INHIBITOR COMPOUNDS AND METHODS OF USE GENENTECH, INC. (US) 2009-10-08 WO disclosed